Related Experiment Video
Updated: May 31, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Thyroid cancer: is ethnicity relevant?
1ENT Department, Heartlands Hospital, Birmingham, UK. tiragalm@yahoo.com
The Journal of Laryngology and Otology
|July 7, 2011
Summary
Asian women present with thyroid cancer at a younger age compared to Caucasian women. This study highlights ethnic variations in thyroid cancer presentation age.
Area of Science:
- Endocrinology
- Oncology
- Epidemiology
Background:
- Thyroid cancer incidence and presentation age can vary across different ethnic groups.
- Understanding these variations is crucial for targeted screening and early diagnosis.
Purpose of the Study:
- To determine the age at which diverse ethnic groups present with thyroid cancer.
- To investigate potential ethnic disparities in thyroid cancer presentation age.
Main Methods:
- Retrospective, observational study.
- Data collected from 263 thyroid cancer patients across three West Midlands hospitals (1998-2009).
- Analysis of patient ethnicity, sex, and age at presentation.
Main Results:
- Papillary carcinoma was the predominant type of thyroid cancer.
- Thyroid cancer was more common in women across all ethnic groups.
- Mean presentation age: 50 years (Asians) vs. 56 years (Caucasians).
- Asian women presented significantly younger (mean 46 years) than Caucasian women (mean 56 years).
Conclusions:
- Asian women present with thyroid cancer at a significantly younger mean age than Caucasian women.
- Ethnic background is an important factor in thyroid cancer presentation age.
Related Concept Videos
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...